A carregar...
Convergence of IPMK and LKB1-AMPK Signaling Pathways on Metformin Action
Metformin is a biguanide drug that is widely prescribed for type 2 diabetes. Metformin suppresses hepatic gluconeogenesis and increases fatty acid oxidation. Although studies have suggested that metformin acts, at least in part, via activation of the liver kinase B1 (LKB1)/AMP-activated protein kina...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Endocrine Society
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4075158/ https://ncbi.nlm.nih.gov/pubmed/24877601 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/me.2014-1134 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|